ENTA Competitors & Alternatives
Compare Enanta Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
ENTA
Main Stock$12.96
Tradestie Score
40
Market Cap
$226.82M
Revenue Growth
-0.2%
Analyst Upside
+52.8%
Top Competitors
235 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DRUG
Bright Minds Biosciences Inc. Common Stock
|
$63.18
|
$410.79M | - | 54 | Compare |
|
FDMT
4D Molecular Therapeutics, Inc. Common Stock
|
$13.17
|
$407.71M | - | 42 | Compare |
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$14.63
|
$386.68M | - | 40 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$7.00
|
$382.04M | - | 45 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$14.43
|
$371.64M | - | 53 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$20.59
|
$354.45M | - | 41 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$44.63
|
$353.70M | - | 46 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.80
|
$350.98M | - | 35 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$3.27
|
$341.56M | - | 36 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$3.94
|
$332.96M | - | 42 | Compare |
More ENTA Analysis
Data updated: Sep 13, 2026 | Industry: Biotechnology (SIC 2834)
235 stocks in this industry